Dr. Parissa Tabrizian is a distinguished physician specializing in liver transplantation and hepatobiliary surgery, currently serving as an Associate Professor at the Recanati/Miller Transplantation Institute, Mount Sinai Health System, New York. With extensive experience in both clinical and research settings, Dr. Tabrizian has developed a prominent career focusing on advanced surgical techniques, liver transplantation, and clinical research. Her work emphasizes the integration of innovative treatments and multidisciplinary approaches in the management of liver diseases and cancer.
Author Metrics
Google Scholar Profile
Dr. Tabrizian’s contributions to the field are reflected in her impactful research and academic achievements. Her publications have been influential in advancing understanding in liver transplantation and hepatobiliary surgery. As a respected reviewer for several high-impact journals, she has also contributed to the quality and dissemination of scientific research in her specialties.
Citations: This typically refers to the total number of times a particular work or body of work has been cited by other researchers. For instance, “2008” could be the total citations for one researcher or paper, and “1762” for another.
h-index: This metric measures both the productivity and citation impact of a researcher. An h-index of 10 means the researcher has 10 papers each cited at least 10 times.
i10-index: This measures the number of papers with at least 10 citations. An i10-index of 10 means the researcher has 10 papers with at least 10 citations each.
Education
Dr. Tabrizian’s educational background is marked by rigorous training and prestigious institutions. She completed her medical degree at Universität Wien, Vienna, Austria, before undertaking advanced surgical training and fellowships at Mount Sinai Medical Center and the Recanati/Miller Transplantation Institute. Her academic journey includes a Master’s in Clinical Research from the Icahn School of Medicine at Mount Sinai, which underpins her expertise in evidence-based medicine and clinical research methodologies.
Research Focus
Dr. Tabrizian’s research primarily revolves around liver transplantation, hepatocellular carcinoma, and surgical oncology. Her work explores innovative approaches to treatment, such as neoadjuvant therapies and adjuvant immunotherapies, with a focus on improving patient outcomes in liver cancer and transplantation. She is involved in several high-profile research projects and trials, reflecting her commitment to advancing the field through scientific inquiry and clinical application.
Professional Journey
Dr. Tabrizian’s professional journey spans over two decades of dedicated service and research in the medical field. Starting from her residency and fellowships in general and surgical oncology, she advanced to her current role as an Associate Professor. Her career includes notable roles such as the Director of Liver Surgery Quality and Residency Education at the Recanati/Miller Transplantation Institute, illustrating her leadership and expertise in transplant surgery and medical education.
Honors & Awards
Dr. Tabrizian has received numerous accolades for her contributions to surgery and education. Among these, she has been recognized by Alpha Omega Alpha, the IME House Staff Excellence in Teaching Award, and the Arthur Aufses Junior Prize in Surgery. These honors highlight her excellence in both clinical practice and teaching, underscoring her impact on her peers and students.
Publications Noted & Contributions
Dr. Tabrizian’s publications are well-regarded in the field of liver transplantation and hepatobiliary surgery. Her research contributions are frequently cited in major medical journals, reflecting the significance of her work. She has also been involved in key conferences and symposiums, where she has shared her insights and findings with the broader medical community.
Current Management of Hepatocellular Carcinoma
- Authors: P Tabrizian, S Roayaie, ME Schwartz
- Journal: World Journal of Gastroenterology (WJG)
- Year: 2014
- Volume & Issue: 20 (30), 10223
- Citations: 95
- Summary: This article provides an overview of the contemporary approaches to managing hepatocellular carcinoma, discussing various treatment options and strategies.
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
- Authors: P Tabrizian, ML Holzner, N Mehta, K Halazun, VG Agopian, F Yao, et al.
- Journal: JAMA Surgery
- Year: 2022
- Volume & Issue: 157 (9), 779-788
- Citations: 86
- Summary: This study examines the long-term outcomes of liver transplantation combined with downstaging for patients with hepatocellular carcinoma, highlighting survival rates and prognostic factors.
Prolonged Hypernutrition Impairs TREM2-Dependent Efferocytosis to License Chronic Liver Inflammation and NASH Development
- Authors: X Wang, Q He, C Zhou, Y Xu, D Liu, N Fujiwara, N Kubota, A Click, et al.
- Journal: Immunity
- Year: 2023
- Volume & Issue: 56 (1), 58-77.e11
- Citations: 78
- Summary: This research explores how prolonged hypernutrition affects TREM2-dependent efferocytosis, contributing to chronic liver inflammation and the development of nonalcoholic steatohepatitis (NASH).
Radiation Segmentectomy for Curative Intent of Unresectable Very Early to Early Stage Hepatocellular Carcinoma (RASER): A Single-Centre, Single-Arm Study
- Authors: E Kim, A Sher, G Abboud, M Schwartz, M Facciuto, P Tabrizian, et al.
- Journal: The Lancet Gastroenterology & Hepatology
- Year: 2022
- Volume & Issue: 7 (9), 843-850
- Citations: 73
- Summary: This study investigates the efficacy of radiation segmentectomy for patients with unresectable early-stage hepatocellular carcinoma, focusing on its potential as a curative treatment option.
Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data
- Authors: CH Wassmer, S El Hajji, X Papazarkadas, P Compagnon, P Tabrizian, et al.
- Journal: Cancers
- Year: 2023
- Volume & Issue: 15 (18), 4574
- Citations: 18
- Summary: This review discusses the integration of immunotherapy with liver transplantation, summarizing current basic and clinical research on the topic.
Research Timeline
Dr. Tabrizian’s research timeline showcases a progressive career in clinical and translational research. Starting with foundational studies on hepatocellular carcinoma and liver transplantation, her research has evolved to include cutting-edge clinical trials and multicohort studies. Her ongoing projects and contributions to various research studies highlight her active role in shaping future developments in her field.
Collaborations and Projects
Dr. Tabrizian collaborates with leading experts and institutions on various high-impact projects. Her involvement includes roles as a co-investigator in multi-cohort studies, the Mount Sinai Liver Cancer SPORE, and other significant research initiatives. These collaborations reflect her commitment to advancing medical knowledge and improving patient care through cooperative and interdisciplinary efforts.
Conclusion
Dr. Parissa Tabrizian’s career exemplifies excellence in liver transplantation and hepatobiliary surgery, marked by groundbreaking research, impactful publications, and prestigious awards. Her work has significantly advanced the understanding and treatment of liver diseases and cancer. However, to further enhance her impact, Dr. Tabrizian could focus on broader dissemination of her findings, increase interdisciplinary and patient-centric research, and ensure diverse populations are represented in her studies. By addressing these areas, she can continue to lead in both academic and clinical spheres, ultimately translating her research into improved patient outcomes and practice standards.